Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Wispelwey

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Drug Safety|May 1, 1990
Pentamidine. A risk-benefit analysisB Wispelwey, R Pearson
Infection Control and Hospital Epidemiology|June 1, 1991
Pentamidine: a reviewB Wispelwey, R D Pearson
Infectious Disease Clinics of North America|December 1, 1991
Pharmacologic interventions aimed at preventing the biologic effects of endotoxinC A Sable, B Wispelwey
Journal of Clinical Gastroenterology|April 1, 1996
Mycobacterium avium complex peritonitis in a patient with alcoholic liver diseaseK A Adal, B Wispelwey
Diagnostic Microbiology and Infectious Disease|March 1, 1990
Ciprofloxacin in the treatment of Staphylococcus aureus osteomyelitis. A reviewB Wispelwey, W M Scheld
Seminars in Neurology|October 29, 2000
Brain abscessD P Calfee, B Wispelwey
Seminars in Neurology|September 1, 1992
Brain abscessB Wispelwey, W M Scheld
Clinical Neuropharmacology|December 1, 1987
Brain abscessB Wispelwey, W M Scheld
The Pediatric Infectious Disease Journal|December 1, 1989
Potential role of host cytokines in Haemophilus influenzae lipopolysaccharide-induced blood-brain barrier permeabilityW M Scheld, V J Quagliarello, B Wispelwey
Infection and Immunity|August 1, 1989
Haemophilus influenzae outer membrane vesicle-induced blood-brain barrier permeability during experimental meningitisB Wispelwey, E J Hansen, W M Scheld
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Drug Safety|May 1, 1990
Pentamidine. A risk-benefit analysisB Wispelwey, R Pearson
Infection Control and Hospital Epidemiology|June 1, 1991
Pentamidine: a reviewB Wispelwey, R D Pearson
Infectious Disease Clinics of North America|December 1, 1991
Pharmacologic interventions aimed at preventing the biologic effects of endotoxinC A Sable, B Wispelwey
Journal of Clinical Gastroenterology|April 1, 1996
Mycobacterium avium complex peritonitis in a patient with alcoholic liver diseaseK A Adal, B Wispelwey
Diagnostic Microbiology and Infectious Disease|March 1, 1990
Ciprofloxacin in the treatment of Staphylococcus aureus osteomyelitis. A reviewB Wispelwey, W M Scheld
Seminars in Neurology|October 29, 2000
Brain abscessD P Calfee, B Wispelwey
Seminars in Neurology|September 1, 1992
Brain abscessB Wispelwey, W M Scheld
Clinical Neuropharmacology|December 1, 1987
Brain abscessB Wispelwey, W M Scheld
The Pediatric Infectious Disease Journal|December 1, 1989
Potential role of host cytokines in Haemophilus influenzae lipopolysaccharide-induced blood-brain barrier permeabilityW M Scheld, V J Quagliarello, B Wispelwey
Infection and Immunity|August 1, 1989
Haemophilus influenzae outer membrane vesicle-induced blood-brain barrier permeability during experimental meningitisB Wispelwey, E J Hansen, W M Scheld
Pageof 3